Biotek-snakken — Juli 2024
-
Anavex Presents Results From Phase IIb/III Trial Of Blarcamesine In Alzheimer's Disease https://proinvestor.com/investornyt/1191535/anavex-presents-results-from-phase-iib-iii-trial-of-blarcamesine-in-alzheimers-disease
-
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia. https://proinvestor.com/investornyt/1191579/attention-growth-investors-this-biotech-stock-is-crushing-nvidia
-
Biotech Stocks Facing FDA Decision In August 2024 https://proinvestor.com/investornyt/1191575/biotech-stocks-facing-fda-decision-in-august-2024
-
Cessatech deltager i IASP 2024 World Congress on Pain i Amsterdam 6. Aug med oplæg. https://posters.worldcongress2024.org/poster/developing-a-novel-pediatric-intranasal-analgesic-using-pk-pd-modeling-to-obtain-adequate-dosing/?fbclid=IwY2xjawEUcqBleHRuA2FlbQIxMAABHVKtLxM4K0SbBAE7pD_OKAyo6niXgQaaLajOmjKkFzO3M70b7Ig50yd9eQ_aem_tD5hFHOMpSQglFMYNoyM4g
-
-
- August er der Q2 regnskab. 28. Aug company presentation. Markedet afventer om USA salget er kommet igang. Skulle
efter planen være nu... og så er dagens slutkurs 7,40 samtidig en delt ATH med 2. Januar... Venligst pil mig ned med konstruktiv kritik; jeg er ved at være (alt for) optimistisk
Hvad kan gå galt? En masse, bl.a. forsinkelser og sløve salgstal...men synes at det virker solidt og lovende pt.
- August er der Q2 regnskab. 28. Aug company presentation. Markedet afventer om USA salget er kommet igang. Skulle
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind